{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T21:07:17Z","timestamp":1784408837001,"version":"3.55.0"},"reference-count":14,"publisher":"Japan Neurosurgical Society","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.2176\/jns-nmc.2024-0296","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T22:10:03Z","timestamp":1749593403000},"page":"255-260","source":"Crossref","is-referenced-by-count":1,"title":["Recurrence of Central Nervous System Methotrexate-related Lymphoproliferative Disorder after Methotrexate Discontinuation: A Case Report"],"prefix":"10.2176","volume":"12","author":[{"given":"Yoshihiro","family":"OKADA","sequence":"first","affiliation":[{"name":"Department of Neurosurgery and Neuroendovascular Surgery, Hiroshima City Hiroshima Citizens Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"TOMITA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Neuroendovascular Surgery, Hiroshima City Hiroshima Citizens Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisakazu","family":"NISHIMORI","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hiroshima City Hiroshima Citizens Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"UENO","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hiroshima City Hiroshima Citizens Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanji","family":"MATSUURA","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Hiroshima City Hiroshima Citizens Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"MAKINO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Neuroendovascular Surgery, Hiroshima City Hiroshima Citizens Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"KIDANI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Neuroendovascular Surgery, Hiroshima City Hiroshima Citizens Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"MURAOKA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Neuroendovascular Surgery, Hiroshima City Hiroshima Citizens Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"HIROTSUNE","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Neuroendovascular Surgery, Hiroshima City Hiroshima Citizens Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"NISHINO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Neuroendovascular Surgery, Hiroshima City Hiroshima Citizens Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"971","reference":[{"key":"1","unstructured":"1) Gaulard PS, Swerdlow SH, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Swerdlow SH, Campo E, Harris NL, et al (eds). Lyon France: IARC; 2017. Other iatrogenic immunodeficiency-associated lymphoproliferative disorders; p. 462-4."},{"key":"2","doi-asserted-by":"publisher","unstructured":"2) Ueno H, Ohno N, Abe T, et al. Prognosis prediction using magnetic resonance spectroscopy and oligoclonal bands in central nervous system methotrexate-associated lymphoproliferative disorder. Intern Med. 2022;61 (24):3733-8. doi: 10.2169\/internalmedicine.9296-21","DOI":"10.2169\/internalmedicine.9296-21"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3) Gion Y, Iwaki N, Takata K, et al. Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types. Cancer Sci. 2017;108 (6):1271-80. doi: 10.1111\/cas.13249","DOI":"10.1111\/cas.13249"},{"key":"4","unstructured":"4) Hoshida Y, Xu JX, Fujita S, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol. 2007;34 (2):322-31."},{"key":"5","doi-asserted-by":"publisher","unstructured":"5) Tokuhira M, Saito S, Okuyama A, et al. Clinicopathologic investigation of methotrexate-induced lymphoproliferative disorders, with a focus on regression. Leuk Lymphoma. 2018;59 (5):1143-52. doi: 10.1080\/10428194.2017.1369073","DOI":"10.1080\/10428194.2017.1369073"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6) In A, Stopa BM, Cuoco JA, et al. Central nervous system lymphoproliferative disorder secondary to methotrexate: a systematic literature review and case illustration. World Neurosurg. 2023;179:118-26. doi: 10.1016\/j.wneu.2023.08.018","DOI":"10.1016\/j.wneu.2023.08.018"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7) Ejima-Yamada K, Oshiro Y, Okamura S, et al. Epstein-Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders. Virchows Arch. 2017;470 (2):205-15. doi: 10.1007\/s00428-016-2030-x","DOI":"10.1007\/s00428-016-2030-x"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8) Kato T, Imaizumi Y, Itonaga H, et al. Methotrexate-related lymphoproliferative disease showing different histological findings at recurrence. Rinsho Ketsueki. 2023;64 (2):97-101. doi: 10.11406\/rinketsu.64.97","DOI":"10.11406\/rinketsu.64.97"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9) Omid-Fard N, Puac-Polanco P, Torres CH, et al. Imaging features of immunodeficiency-associated primary CNS lymphoma: a review. Can Assoc Radiol J. 2025;76 (1):113-21. doi: 10.1177\/08465371241259951","DOI":"10.1177\/08465371241259951"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10) Sutherland T, Yap K, Liew E, et al. Primary central nervous system lymphoma in immunocompetent patients: a retrospective review of MRI features. J Med Imaging Radiat Oncol. 2012;56 (3):295-301. doi: 10.1111\/j.1754-9485.2012.02366.x","DOI":"10.1111\/j.1754-9485.2012.02366.x"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11) Ambady P, Fu R, Netto JP, et al. Patterns of relapse in primary central nervous system lymphoma: inferences regarding the role of the neuro-vascular unit and monoclonal antibodies in treating occult CNS disease. Fluids Barriers CNS. 2017;14 (1):16. doi: 10.1186\/s12987-017-0064-3","DOI":"10.1186\/s12987-017-0064-3"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12) Kato T, Mizumoto C, Inoue F, et al. Methotrexate-related other iatrogenic immunodeficiency-associated lymphoproliferative disorder in the CNS and medication-related osteonecrosis of the jaw occurring simultaneously: a case report. Exp Ther Med. 2024;27 (1):41. doi: 10.3892\/etm.2023.12329","DOI":"10.3892\/etm.2023.12329"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13) Yahalom J, Illidge T, Specht L, et al. Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2015;92 (1):11-31. doi: 10.1016\/j.ijrobp.2015.01.009","DOI":"10.1016\/j.ijrobp.2015.01.009"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14) Liu W, Xue J, Yu S, et al. Primary central nervous system lymphoma mimicking recurrent depressive disorder: a case report. Oncol Lett. 2015;9 (4):1819-21. doi: 10.3892\/ol.2015.2963","DOI":"10.3892\/ol.2015.2963"}],"container-title":["NMC Case Report Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/12\/0\/12_2024-0296\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T03:37:34Z","timestamp":1749872254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/12\/0\/12_2024-0296\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":14,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2176\/jns-nmc.2024-0296","relation":{},"ISSN":["2188-4226"],"issn-type":[{"value":"2188-4226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]},"article-number":"2024-0296"}}